SIP 1.55% $1.31 sigma pharmaceuticals limited

Yes a lot to like, as you said. Next to no debt, great market...

  1. 8,835 Posts.
    lightbulb Created with Sketch. 1048
    Yes a lot to like, as you said. Next to no debt, great market share , only down size is low EBIT because of the nature of the business. That is why, imo, that the need to expand into other areas with higher EBIT is important. Areas like hospital distribution, private label come to mind. Only head winds I can see it the budget deficit putting political pressure to cut costs in the distribution area.
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.